Susan E. Barrowcliffe, General Manager, Europe at Aimmune Therapeutics, Inc. (AIMT), sold 18,390 shares at $22.00 ($405K) on 2017-09-05, disclosed to the SEC on 2017-09-07.
Open-market sale of $405k AIMT by General Manager, Europe. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 3,223 | $71K | 17.5% |
| 2 | $22.00 | 15,167 | $334K | 82.5% |
| Total | $22.00 avg | 18,390 | $405K | 100% |
| Filing → |
| AIMT | SELL | 2017-09-27 | $500K | — | Filing → |
| AIMT | SELL | 2017-07-31 | $11K | — | Filing → |
| AIMT | SELL | 2017-07-25 | $134K | — | Filing → |